219 related articles for article (PubMed ID: 34198746)
1. 'Carbon-Monoxide-Releasing Molecule-2 (CORM-2)' Is a Misnomer: Ruthenium Toxicity, Not CO Release, Accounts for Its Antimicrobial Effects.
Southam HM; Williamson MP; Chapman JA; Lyon RL; Trevitt CR; Henderson PJF; Poole RK
Antioxidants (Basel); 2021 Jun; 10(6):. PubMed ID: 34198746
[TBL] [Abstract][Full Text] [Related]
2. A thiol-reactive Ru(II) ion, not CO release, underlies the potent antimicrobial and cytotoxic properties of CO-releasing molecule-3.
Southam HM; Smith TW; Lyon RL; Liao C; Trevitt CR; Middlemiss LA; Cox FL; Chapman JA; El-Khamisy SF; Hippler M; Williamson MP; Henderson PJF; Poole RK
Redox Biol; 2018 Sep; 18():114-123. PubMed ID: 30007887
[TBL] [Abstract][Full Text] [Related]
3. Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications.
Winburn IC; Gunatunga K; McKernan RD; Walker RJ; Sammut IA; Harrison JC
Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):31-41. PubMed ID: 22269084
[TBL] [Abstract][Full Text] [Related]
4. Examining the antimicrobial activity and toxicity to animal cells of different types of CO-releasing molecules.
Nobre LS; Jeremias H; Romão CC; Saraiva LM
Dalton Trans; 2016 Jan; 45(4):1455-66. PubMed ID: 26673556
[TBL] [Abstract][Full Text] [Related]
5. Development of Triggerable, Trackable, and Targetable Carbon Monoxide Releasing Molecules.
Lazarus LS; Benninghoff AD; Berreau LM
Acc Chem Res; 2020 Oct; 53(10):2273-2285. PubMed ID: 32929957
[TBL] [Abstract][Full Text] [Related]
6. The Broad-Spectrum Antimicrobial Potential of [Mn(CO)
Wareham LK; McLean S; Begg R; Rana N; Ali S; Kendall JJ; Sanguinetti G; Mann BE; Poole RK
Antioxid Redox Signal; 2018 May; 28(14):1286-1308. PubMed ID: 28816060
[TBL] [Abstract][Full Text] [Related]
7. Plight of CORMs: The unreliability of four commercially available CO-releasing molecules, CORM-2, CORM-3, CORM-A1, and CORM-401, in studying CO biology.
Bauer N; Yuan Z; Yang X; Wang B
Biochem Pharmacol; 2023 Aug; 214():115642. PubMed ID: 37321416
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics of
Carvalho SM; Marques J; Romão CC; Saraiva LM
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332064
[TBL] [Abstract][Full Text] [Related]
9. Effects of frequently applied carbon monoxide releasing molecules (CORMs) in typical CO-sensitive model systems - A comparative in vitro study.
Stucki D; Krahl H; Walter M; Steinhausen J; Hommel K; Brenneisen P; Stahl W
Arch Biochem Biophys; 2020 Jul; 687():108383. PubMed ID: 32335048
[TBL] [Abstract][Full Text] [Related]
10. CO-independent modification of K
Gessner G; Sahoo N; Swain SM; Hirth G; Schönherr R; Mede R; Westerhausen M; Brewitz HH; Heimer P; Imhof D; Hoshi T; Heinemann SH
Eur J Pharmacol; 2017 Nov; 815():33-41. PubMed ID: 28987271
[TBL] [Abstract][Full Text] [Related]
11. Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules.
Desmard M; Foresti R; Morin D; Dagouassat M; Berdeaux A; Denamur E; Crook SH; Mann BE; Scapens D; Montravers P; Boczkowski J; Motterlini R
Antioxid Redox Signal; 2012 Jan; 16(2):153-63. PubMed ID: 21864022
[TBL] [Abstract][Full Text] [Related]
12. Carbon monoxide releasing molecule 401 (CORM-401) modulates phase I metabolism of xenobiotics.
Walter M; Stahl W; Brenneisen P; Reichert AS; Stucki D
Toxicol In Vitro; 2019 Sep; 59():215-220. PubMed ID: 31004742
[TBL] [Abstract][Full Text] [Related]
13. Carbon monoxide-releasing molecules inhibit the cystic fibrosis transmembrane conductance regulator Cl
Rodrat M; Jantarajit W; Ng DRS; Harvey BSJ; Liu J; Wilkinson WJ; Charoenphandhu N; Sheppard DN
Am J Physiol Lung Cell Mol Physiol; 2020 Dec; 319(6):L997-L1009. PubMed ID: 32936026
[TBL] [Abstract][Full Text] [Related]
14. Ru(CO)3Cl(Glycinate) (CORM-3): a carbon monoxide-releasing molecule with broad-spectrum antimicrobial and photosensitive activities against respiration and cation transport in Escherichia coli.
Wilson JL; Jesse HE; Hughes B; Lund V; Naylor K; Davidge KS; Cook GM; Mann BE; Poole RK
Antioxid Redox Signal; 2013 Aug; 19(5):497-509. PubMed ID: 23186316
[TBL] [Abstract][Full Text] [Related]
15. Exploring the antimicrobial action of a carbon monoxide-releasing compound through whole-genome transcription profiling of Escherichia coli.
Nobre LS; Al-Shahrour F; Dopazo J; Saraiva LM
Microbiology (Reading); 2009 Mar; 155(Pt 3):813-824. PubMed ID: 19246752
[TBL] [Abstract][Full Text] [Related]
16. Interaction of carbon monoxide-releasing ruthenium carbonyl CORM-3 with plasma fibronectin.
Aki T; Unuma K; Noritake K; Kurahashi H; Funakoshi T; Uemura K
Toxicol In Vitro; 2018 Aug; 50():201-209. PubMed ID: 29580987
[TBL] [Abstract][Full Text] [Related]
17. CO-Releasing Molecules Have Nonheme Targets in Bacteria: Transcriptomic, Mathematical Modeling and Biochemical Analyses of CORM-3 [Ru(CO)3Cl(glycinate)] Actions on a Heme-Deficient Mutant of Escherichia coli.
Wilson JL; Wareham LK; McLean S; Begg R; Greaves S; Mann BE; Sanguinetti G; Poole RK
Antioxid Redox Signal; 2015 Jul; 23(2):148-62. PubMed ID: 25811604
[TBL] [Abstract][Full Text] [Related]
18. Water-Soluble Carbon Monoxide-Releasing Molecules (CORMs).
Khan H; Faizan M; Niazi SUK; Madiha ; Muhammad N; Zhang W
Top Curr Chem (Cham); 2022 Dec; 381(1):3. PubMed ID: 36515756
[TBL] [Abstract][Full Text] [Related]
19. Ruthenium, Not Carbon Monoxide, Inhibits the Procoagulant Activity of
Nielsen VG
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340168
[TBL] [Abstract][Full Text] [Related]
20. Carbon monoxide releasing molecule-2 (CORM-2) inhibits growth of multidrug-resistant uropathogenic Escherichia coli in biofilm and following host cell colonization.
Sahlberg Bang C; Kruse R; Johansson K; Persson K
BMC Microbiol; 2016 Apr; 16():64. PubMed ID: 27067266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
